ロード中...
Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype
BACKGROUND: Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C. However, the precise mechanisms underlying RBV action against hepatitis C virus (HCV) replication are not yet understood....
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336140/ https://ncbi.nlm.nih.gov/pubmed/25699517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0118313 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|